FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageuz.dhp.core
Resource TypeQuestionnaire
IdQuestionnaire-CVDRiskScreeningQuestionnaire.json
FHIR VersionR5
Sourcehttps://build.fhir.org/ig/uzinfocom-org/digital-health-ig/Questionnaire-CVDRiskScreeningQuestionnaire.html
URLhttps://dhp.uz/fhir/core/Questionnaire/CVDRiskScreeningQuestionnaire
Version0.6.0
Statusdraft
Date2026-07-27T06:14:18+00:00
NameCVDRiskScreeningQuestionnaire
TitleYurak-qon tomir kasalliklari xavfini erta aniqlash skriningi
DescriptionDMed qabulida bemor uchun so'rovnoma: yosh, jins, vazn, bo'y, TVI, arterial bosim va tamaki mahsulotlari iste'moli.

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source


English


Generated Narrative: Questionnaire CVDRiskScreeningQuestionnaire

Language: uz

Profile: UZ Core Questionnaire version: 0.6.0

Structure
LinkIDTextCardinalityTypeFlagsDescription & Constraintsdoco
.. CVDRiskScreeningQuestionnaireDMed qabulida bemor uchun so'rovnoma: yosh, jins, vazn, bo'y, TVI, arterial bosim va tamaki mahsulotlari iste'moli.Questionnairehttps://dhp.uz/fhir/core/Questionnaire/CVDRiskScreeningQuestionnaire#0.6.0
... ageYosh1..1integer
... sexJins1..1codingOptions: 4 options
... weightVazn1..1decimal
... heightBo'y1..1decimal
... bmiTana vazni indeksi0..1decimaliconicon
... systolic-bpSistolik bosim1..1decimal
... diastolic-bpDiastolik bosim1..1decimal
... tobacco-useTamaki mahsulotlarini iste'mol qilish1..1codingOptions: 3 options
... cvd-risk-resultYurak-qon tomir kasalliklari xavfini baholash0..1group
.... cvd-risk-score10 yillik xavf (%)0..1integericonicon
.... cvd-risk-categoryXavf darajasi0..1codingiconiconOptions: 5 options
.... recommendation-lowSog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv 12 oydan keyin o'tkaziladi.0..1displayEnable When: cvd-risk-score < 5
.... recommendation-moderateSog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv har uch oyda o'tkaziladi (arterial bosimning maqsadli darajasiga erishilganda - takroriy tekshiruvlar har 6-9 oyda amalga oshiriladi). Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'zlar ko'ruvi, EKG - 2 yilda 1 marta yoki ko'rsatma bo'yicha.0..1displayEnable When:
.... recommendation-mediumSog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta.0..1displayEnable When:
.... recommendation-highSog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Lipid spektri va qondagi kreatinin darajasi hamda koptokchali filtratsiya tezligi (KFT) hisobi reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta.0..1displayEnable When: cvd-risk-score >= 20

doco Documentation for this format

Options Sets

Answer options for sex

  • http://hl7.org/fhir/administrative-gender#male ("Male")
  • http://hl7.org/fhir/administrative-gender#female ("Female")
  • http://hl7.org/fhir/administrative-gender#other ("Other")
  • http://hl7.org/fhir/administrative-gender#unknown ("Unknown")

Answer options for tobacco-use

  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-tobacco-use-cs#not-use ("Iste'mol qilmaydi")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-tobacco-use-cs#use ("Iste'mol qiladi")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-tobacco-use-cs#quit ("Tashlagan")

Answer options for cvd-risk-category

  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#low ("Past xavf (<5%)")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#moderate ("O'rtacha xavf (5% - <10%)")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#medium ("O'rtacha xavf (10% - <20%)")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#high ("Yuqori xavf (20% - <30%)")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#very-high ("Juda yuqori xavf (>=30%)")

Russian


Сгенерированный нарратив: Questionnaire CVDRiskScreeningQuestionnaire

Язык: uz

Профиль: UZ Core Questionnaire версия: 0.6.0

Структура
LinkIDТекстКардинальностьТипФлагиОписание и ограниченияdoco
.. CVDRiskScreeningQuestionnaireDMed qabulida bemor uchun so'rovnoma: yosh, jins, vazn, bo'y, TVI, arterial bosim va tamaki mahsulotlari iste'moli.Questionnairehttps://dhp.uz/fhir/core/Questionnaire/CVDRiskScreeningQuestionnaire#0.6.0
... ageYosh1..1integer
... sexJins1..1codingПараметры: 4 options
... weightVazn1..1decimal
... heightBo'y1..1decimal
... bmiTana vazni indeksi0..1decimaliconicon
... systolic-bpSistolik bosim1..1decimal
... diastolic-bpDiastolik bosim1..1decimal
... tobacco-useTamaki mahsulotlarini iste'mol qilish1..1codingПараметры: 3 options
... cvd-risk-resultYurak-qon tomir kasalliklari xavfini baholash0..1group
.... cvd-risk-score10 yillik xavf (%)0..1integericonicon
.... cvd-risk-categoryXavf darajasi0..1codingiconiconПараметры: 5 options
.... recommendation-lowSog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv 12 oydan keyin o'tkaziladi.0..1displayВключить когда: cvd-risk-score < 5
.... recommendation-moderateSog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv har uch oyda o'tkaziladi (arterial bosimning maqsadli darajasiga erishilganda - takroriy tekshiruvlar har 6-9 oyda amalga oshiriladi). Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'zlar ko'ruvi, EKG - 2 yilda 1 marta yoki ko'rsatma bo'yicha.0..1displayВключить когда:
.... recommendation-mediumSog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta.0..1displayВключить когда:
.... recommendation-highSog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Lipid spektri va qondagi kreatinin darajasi hamda koptokchali filtratsiya tezligi (KFT) hisobi reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta.0..1displayВключить когда: cvd-risk-score >= 20

doco Документация для этого формата

Наборы параметров

Варианты ответов для sex

  • http://hl7.org/fhir/administrative-gender#male ("Male")
  • http://hl7.org/fhir/administrative-gender#female ("Female")
  • http://hl7.org/fhir/administrative-gender#other ("Other")
  • http://hl7.org/fhir/administrative-gender#unknown ("Unknown")

Варианты ответов для tobacco-use

  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-tobacco-use-cs#not-use ("Iste'mol qilmaydi")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-tobacco-use-cs#use ("Iste'mol qiladi")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-tobacco-use-cs#quit ("Tashlagan")

Варианты ответов для cvd-risk-category

  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#low ("Past xavf (<5%)")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#moderate ("O'rtacha xavf (5% - <10%)")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#medium ("O'rtacha xavf (10% - <20%)")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#high ("Yuqori xavf (20% - <30%)")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#very-high ("Juda yuqori xavf (>=30%)")

Uzbek


Generated Narrative: Questionnaire CVDRiskScreeningQuestionnaire

Language: uz

Profile: UZ Core Questionnaire version: 0.6.0

Structure
LinkIDTextCardinalityTypeFlagsDescription & Constraintsdoco
.. CVDRiskScreeningQuestionnaireDMed qabulida bemor uchun so'rovnoma: yosh, jins, vazn, bo'y, TVI, arterial bosim va tamaki mahsulotlari iste'moli.Questionnairehttps://dhp.uz/fhir/core/Questionnaire/CVDRiskScreeningQuestionnaire#0.6.0
... ageYosh1..1integer
... sexJins1..1codingOptions: 4 options
... weightVazn1..1decimal
... heightBo'y1..1decimal
... bmiTana vazni indeksi0..1decimaliconicon
... systolic-bpSistolik bosim1..1decimal
... diastolic-bpDiastolik bosim1..1decimal
... tobacco-useTamaki mahsulotlarini iste'mol qilish1..1codingOptions: 3 options
... cvd-risk-resultYurak-qon tomir kasalliklari xavfini baholash0..1group
.... cvd-risk-score10 yillik xavf (%)0..1integericonicon
.... cvd-risk-categoryXavf darajasi0..1codingiconiconOptions: 5 options
.... recommendation-lowSog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv 12 oydan keyin o'tkaziladi.0..1displayEnable When: cvd-risk-score < 5
.... recommendation-moderateSog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv har uch oyda o'tkaziladi (arterial bosimning maqsadli darajasiga erishilganda - takroriy tekshiruvlar har 6-9 oyda amalga oshiriladi). Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'zlar ko'ruvi, EKG - 2 yilda 1 marta yoki ko'rsatma bo'yicha.0..1displayEnable When:
.... recommendation-mediumSog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta.0..1displayEnable When:
.... recommendation-highSog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Lipid spektri va qondagi kreatinin darajasi hamda koptokchali filtratsiya tezligi (KFT) hisobi reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta.0..1displayEnable When: cvd-risk-score >= 20

doco Documentation for this format

Options Sets

Answer options for sex

  • http://hl7.org/fhir/administrative-gender#male ("Male")
  • http://hl7.org/fhir/administrative-gender#female ("Female")
  • http://hl7.org/fhir/administrative-gender#other ("Other")
  • http://hl7.org/fhir/administrative-gender#unknown ("Unknown")

Answer options for tobacco-use

  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-tobacco-use-cs#not-use ("Iste'mol qilmaydi")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-tobacco-use-cs#use ("Iste'mol qiladi")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-tobacco-use-cs#quit ("Tashlagan")

Answer options for cvd-risk-category

  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#low ("Past xavf (<5%)")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#moderate ("O'rtacha xavf (5% - <10%)")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#medium ("O'rtacha xavf (10% - <20%)")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#high ("Yuqori xavf (20% - <30%)")
  • https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs#very-high ("Juda yuqori xavf (>=30%)")

Source1

{
  "resourceType": "Questionnaire",
  "id": "CVDRiskScreeningQuestionnaire",
  "meta": {
    "profile": [
      "https://dhp.uz/fhir/core/StructureDefinition/uz-core-questionnaire|0.6.0"
    ]
  },
  "language": "uz",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "url": "https://dhp.uz/fhir/core/Questionnaire/CVDRiskScreeningQuestionnaire",
  "version": "0.6.0",
  "name": "CVDRiskScreeningQuestionnaire",
  "title": "Yurak-qon tomir kasalliklari xavfini erta aniqlash skriningi",
  "_title": {
    "extension": [
      {
        "extension": [
          {
            "url": "lang",
            "valueCode": "ru"
          },
          {
            "url": "content",
            "valueString": "Скрининг раннего выявления риска сердечно-сосудистых заболеваний"
          }
        ],
        "url": "http://hl7.org/fhir/StructureDefinition/translation"
      },
      {
        "extension": [
          {
            "url": "lang",
            "valueCode": "en"
          },
          {
            "url": "content",
            "valueString": "Cardiovascular disease risk screening"
          }
        ],
        "url": "http://hl7.org/fhir/StructureDefinition/translation"
      }
    ]
  },
  "status": "draft",
  "subjectType": [
    "Patient"
  ],
  "date": "2026-07-27T06:14:18+00:00",
  "publisher": "Ministry of Health of the Republic of Uzbekistan",
  "_publisher": {
    "extension": [
      {
        "extension": [
          {
            "url": "lang",
            "valueCode": "ru"
          },
          {
            "url": "content",
            "valueString": "Ministry of Health of the Republic of Uzbekistan"
          }
        ],
        "url": "http://hl7.org/fhir/StructureDefinition/translation"
      },
      {
        "extension": [
          {
            "url": "lang",
            "valueCode": "uz"
          },
          {
            "url": "content",
            "valueString": "O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi"
          }
        ],
        "url": "http://hl7.org/fhir/StructureDefinition/translation"
      }
    ]
  },
  "contact": [
    {
      "name": "Ministry of Health of the Republic of Uzbekistan",
      "telecom": [
        {
          "system": "url",
          "value": "https://gov.uz/en/ssv"
        },
        {
          "system": "email",
          "value": "info@ssv.uz"
        }
      ]
    }
  ],
  "description": "DMed qabulida bemor uchun so'rovnoma: yosh, jins, vazn, bo'y, TVI, arterial bosim va tamaki mahsulotlari iste'moli.",
  "_description": {
    "extension": [
      {
        "extension": [
          {
            "url": "lang",
            "valueCode": "ru"
          },
          {
            "url": "content",
            "valueString": "Опросник для DMed при приёме пациента: возраст, пол, вес, рост, ИМТ, артериальное давление и употребление табачных изделий."
          }
        ],
        "url": "http://hl7.org/fhir/StructureDefinition/translation"
      },
      {
        "extension": [
          {
            "url": "lang",
            "valueCode": "en"
          },
          {
            "url": "content",
            "valueString": "Questionnaire for DMed during patient visit: age, sex, weight, height, BMI, blood pressure and tobacco use."
          }
        ],
        "url": "http://hl7.org/fhir/StructureDefinition/translation"
      }
    ]
  },
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "UZ",
          "display": "Uzbekistan"
        }
      ]
    }
  ],
  "item": [
    {
      "linkId": "age",
      "text": "Yosh",
      "_text": {
        "extension": [
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "ru"
              },
              {
                "url": "content",
                "valueString": "Возраст"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          },
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "en"
              },
              {
                "url": "content",
                "valueString": "Age"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          }
        ]
      },
      "type": "integer",
      "required": true
    },
    {
      "linkId": "sex",
      "text": "Jins",
      "_text": {
        "extension": [
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "ru"
              },
              {
                "url": "content",
                "valueString": "Пол"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          },
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "en"
              },
              {
                "url": "content",
                "valueString": "Sex"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          }
        ]
      },
      "type": "coding",
      "required": true,
      "answerOption": [
        {
          "valueCoding": {
            "system": "http://hl7.org/fhir/administrative-gender",
            "code": "male",
            "display": "Male",
            "_display": {
              "extension": [
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "ru"
                    },
                    {
                      "url": "content",
                      "valueString": "Мужской"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                },
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "uz"
                    },
                    {
                      "url": "content",
                      "valueString": "Erkak"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                }
              ]
            }
          }
        },
        {
          "valueCoding": {
            "system": "http://hl7.org/fhir/administrative-gender",
            "code": "female",
            "display": "Female",
            "_display": {
              "extension": [
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "ru"
                    },
                    {
                      "url": "content",
                      "valueString": "Женский"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                },
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "uz"
                    },
                    {
                      "url": "content",
                      "valueString": "Ayol"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                }
              ]
            }
          }
        },
        {
          "valueCoding": {
            "system": "http://hl7.org/fhir/administrative-gender",
            "code": "other",
            "display": "Other",
            "_display": {
              "extension": [
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "ru"
                    },
                    {
                      "url": "content",
                      "valueString": "Другой"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                },
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "uz"
                    },
                    {
                      "url": "content",
                      "valueString": "Boshqa"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                }
              ]
            }
          }
        },
        {
          "valueCoding": {
            "system": "http://hl7.org/fhir/administrative-gender",
            "code": "unknown",
            "display": "Unknown",
            "_display": {
              "extension": [
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "ru"
                    },
                    {
                      "url": "content",
                      "valueString": "Неизвестно"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                },
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "uz"
                    },
                    {
                      "url": "content",
                      "valueString": "Noma'lum"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                }
              ]
            }
          }
        }
      ]
    },
    {
      "linkId": "weight",
      "text": "Vazn",
      "_text": {
        "extension": [
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "ru"
              },
              {
                "url": "content",
                "valueString": "Вес"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          },
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "en"
              },
              {
                "url": "content",
                "valueString": "Weight"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          }
        ]
      },
      "type": "decimal",
      "required": true
    },
    {
      "linkId": "height",
      "text": "Bo'y",
      "_text": {
        "extension": [
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "ru"
              },
              {
                "url": "content",
                "valueString": "Рост"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          },
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "en"
              },
              {
                "url": "content",
                "valueString": "Height"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          }
        ]
      },
      "type": "decimal",
      "required": true
    },
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "weight",
            "language": "text/fhirpath",
            "expression": "%resource.item.where(linkId='weight').answer.value.ofType(decimal).first()"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "height",
            "language": "text/fhirpath",
            "expression": "%resource.item.where(linkId='height').answer.value.ofType(decimal).first()"
          }
        },
        {
          "url": "http://hl7.org/fhir/uv/sdc/StructureDefinition/sdc-questionnaire-calculatedExpression",
          "valueExpression": {
            "description": "BMI from weight and height",
            "language": "text/fhirpath",
            "expression": "iif(%height.exists() and %height > 0 and %weight.exists(), (%weight / ((%height / 100) * (%height / 100))).round(1), {})"
          }
        }
      ],
      "linkId": "bmi",
      "text": "Tana vazni indeksi",
      "_text": {
        "extension": [
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "ru"
              },
              {
                "url": "content",
                "valueString": "Индекс массы тела"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          },
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "en"
              },
              {
                "url": "content",
                "valueString": "Body mass index"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          }
        ]
      },
      "type": "decimal",
      "readOnly": true
    },
    {
      "linkId": "systolic-bp",
      "text": "Sistolik bosim",
      "_text": {
        "extension": [
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "ru"
              },
              {
                "url": "content",
                "valueString": "Систолическое давление"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          },
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "en"
              },
              {
                "url": "content",
                "valueString": "Systolic blood pressure"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          }
        ]
      },
      "type": "decimal",
      "required": true
    },
    {
      "linkId": "diastolic-bp",
      "text": "Diastolik bosim",
      "_text": {
        "extension": [
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "ru"
              },
              {
                "url": "content",
                "valueString": "Диастолическое давление"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          },
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "en"
              },
              {
                "url": "content",
                "valueString": "Diastolic blood pressure"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          }
        ]
      },
      "type": "decimal",
      "required": true
    },
    {
      "linkId": "tobacco-use",
      "text": "Tamaki mahsulotlarini iste'mol qilish",
      "_text": {
        "extension": [
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "ru"
              },
              {
                "url": "content",
                "valueString": "Употребление табачных изделий"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          },
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "en"
              },
              {
                "url": "content",
                "valueString": "Tobacco products use"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          }
        ]
      },
      "type": "coding",
      "required": true,
      "answerOption": [
        {
          "valueCoding": {
            "system": "https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-tobacco-use-cs",
            "code": "not-use",
            "display": "Iste'mol qilmaydi",
            "_display": {
              "extension": [
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "ru"
                    },
                    {
                      "url": "content",
                      "valueString": "Не употребляет"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                },
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "en"
                    },
                    {
                      "url": "content",
                      "valueString": "Does not use"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                }
              ]
            }
          }
        },
        {
          "valueCoding": {
            "system": "https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-tobacco-use-cs",
            "code": "use",
            "display": "Iste'mol qiladi",
            "_display": {
              "extension": [
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "ru"
                    },
                    {
                      "url": "content",
                      "valueString": "Употребляет"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                },
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "en"
                    },
                    {
                      "url": "content",
                      "valueString": "Uses"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                }
              ]
            }
          }
        },
        {
          "valueCoding": {
            "system": "https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-tobacco-use-cs",
            "code": "quit",
            "display": "Tashlagan",
            "_display": {
              "extension": [
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "ru"
                    },
                    {
                      "url": "content",
                      "valueString": "Бросил"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                },
                {
                  "extension": [
                    {
                      "url": "lang",
                      "valueCode": "en"
                    },
                    {
                      "url": "content",
                      "valueString": "Quit"
                    }
                  ],
                  "url": "http://hl7.org/fhir/StructureDefinition/translation"
                }
              ]
            }
          }
        }
      ]
    },
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "weight",
            "language": "text/fhirpath",
            "expression": "%resource.item.where(linkId='weight').answer.value.ofType(decimal).first()"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "height",
            "language": "text/fhirpath",
            "expression": "%resource.item.where(linkId='height').answer.value.ofType(decimal).first()"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "age",
            "language": "text/fhirpath",
            "expression": "%resource.item.where(linkId='age').answer.value.ofType(integer).first()"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "sbp",
            "language": "text/fhirpath",
            "expression": "%resource.item.where(linkId='systolic-bp').answer.value.ofType(decimal).first()"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "sexcode",
            "language": "text/fhirpath",
            "expression": "%resource.item.where(linkId='sex').answer.value.ofType(Coding).code.first()"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "smk",
            "language": "text/fhirpath",
            "expression": "%resource.item.where(linkId='tobacco-use').answer.value.ofType(Coding).code.first()"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "bmi",
            "language": "text/fhirpath",
            "expression": "iif(%height.exists() and %height > 0 and %weight.exists(), %weight / ((%height / 100) * (%height / 100)), {})"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "ageIdx",
            "language": "text/fhirpath",
            "expression": "iif(%age < 45, 0, iif(%age < 50, 1, iif(%age < 55, 2, iif(%age < 60, 3, iif(%age < 65, 4, iif(%age < 70, 5, 6))))))"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "bmiIdx",
            "language": "text/fhirpath",
            "expression": "iif(%bmi < 20, 0, iif(%bmi < 25, 1, iif(%bmi < 30, 2, iif(%bmi < 36, 3, 4))))"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "sbpIdx",
            "language": "text/fhirpath",
            "expression": "iif(%sbp < 120, 0, iif(%sbp < 140, 1, iif(%sbp < 160, 2, iif(%sbp < 180, 3, 4))))"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "sexIdx",
            "language": "text/fhirpath",
            "expression": "iif(%sexcode = 'male', 0, iif(%sexcode = 'female', 1, {}))"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "smkIdx",
            "language": "text/fhirpath",
            "expression": "iif(%smk = 'use', 1, 0)"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "idx",
            "language": "text/fhirpath",
            "expression": "((((%sexIdx * 2 + %smkIdx) * 7 + %ageIdx) * 5 + %sbpIdx) * 5 + %bmiIdx)"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "grid",
            "language": "text/fhirpath",
            "expression": "'01010202030202020304020303040504040507090607081114020202030302030304050404050608050608091208091214180203030405040405060705060709110809111317111316202504040606070506070911080911131611131619231519222732060708101108101113151214161922161922263123263136421011131517131618202318212427322528323742333742485416182023262224273033283135394337414550554751556267030304050604050608110608101317091115202614172330400304050709050709111408101316211215192632182329374706070910120709111418111317212716202531392429364454070911131611131619241518232634222632394731374453621113151822151821263021253035423035414855404754627016192225292225293439303439455140455157645158647177242730343832353944484145505560525762677364697479840101010102020202020302020303030304040505050506060701020202020202030304030304040504050506070707080912020203030303030404050405050607060707081009101112140303040404040505060706070708090910111214131416182105060607070708080909101011121313141517191819212326080910101111121314151516171820202123252626283032351415161718181920222323252628303032343638384043464803030404050404050606060708091010111214161516182124040405050606060708090809111214131416182019212325300606070809080910111212131416181719212326242630333708090911121112141517161719212422242730333134374145111214151615171921232224262931293235384239434650541718192123222426283130323437403942454852505357606424252729313133353840404245485150535559626164687174'"
          }
        },
        {
          "url": "http://hl7.org/fhir/StructureDefinition/variable",
          "valueExpression": {
            "name": "pct",
            "language": "text/fhirpath",
            "expression": "iif(%age >= 40 and %age <= 74 and %sbp.exists() and %bmi.exists() and %sexIdx.exists() and %smk.exists(), %grid.substring(%idx * 2, 2).toInteger(), {})"
          }
        }
      ],
      "linkId": "cvd-risk-result",
      "text": "Yurak-qon tomir kasalliklari xavfini baholash",
      "_text": {
        "extension": [
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "ru"
              },
              {
                "url": "content",
                "valueString": "Оценка риска сердечно-сосудистых заболеваний"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          },
          {
            "extension": [
              {
                "url": "lang",
                "valueCode": "en"
              },
              {
                "url": "content",
                "valueString": "Cardiovascular disease risk assessment"
              }
            ],
            "url": "http://hl7.org/fhir/StructureDefinition/translation"
          }
        ]
      },
      "type": "group",
      "item": [
        {
          "extension": [
            {
              "url": "http://hl7.org/fhir/uv/sdc/StructureDefinition/sdc-questionnaire-calculatedExpression",
              "valueExpression": {
                "description": "WHO/ISH CVD 10-year risk percent looked up from the chart",
                "language": "text/fhirpath",
                "expression": "%pct"
              }
            }
          ],
          "linkId": "cvd-risk-score",
          "text": "10 yillik xavf (%)",
          "_text": {
            "extension": [
              {
                "extension": [
                  {
                    "url": "lang",
                    "valueCode": "ru"
                  },
                  {
                    "url": "content",
                    "valueString": "10-летний риск (%)"
                  }
                ],
                "url": "http://hl7.org/fhir/StructureDefinition/translation"
              },
              {
                "extension": [
                  {
                    "url": "lang",
                    "valueCode": "en"
                  },
                  {
                    "url": "content",
                    "valueString": "10-year risk (%)"
                  }
                ],
                "url": "http://hl7.org/fhir/StructureDefinition/translation"
              }
            ]
          },
          "type": "integer",
          "readOnly": true
        },
        {
          "extension": [
            {
              "url": "http://hl7.org/fhir/uv/sdc/StructureDefinition/sdc-questionnaire-calculatedExpression",
              "valueExpression": {
                "description": "Risk band derived from the calculated risk percent",
                "language": "text/fhirpath",
                "expression": "iif(%pct.exists(), iif(%pct < 5, 'low', iif(%pct < 10, 'moderate', iif(%pct < 20, 'medium', iif(%pct < 30, 'high', 'very-high')))), {})"
              }
            }
          ],
          "linkId": "cvd-risk-category",
          "text": "Xavf darajasi",
          "_text": {
            "extension": [
              {
                "extension": [
                  {
                    "url": "lang",
                    "valueCode": "ru"
                  },
                  {
                    "url": "content",
                    "valueString": "Степень риска"
                  }
                ],
                "url": "http://hl7.org/fhir/StructureDefinition/translation"
              },
              {
                "extension": [
                  {
                    "url": "lang",
                    "valueCode": "en"
                  },
                  {
                    "url": "content",
                    "valueString": "Risk level"
                  }
                ],
                "url": "http://hl7.org/fhir/StructureDefinition/translation"
              }
            ]
          },
          "type": "coding",
          "readOnly": true,
          "answerOption": [
            {
              "valueCoding": {
                "system": "https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs",
                "code": "low",
                "display": "Past xavf (<5%)",
                "_display": {
                  "extension": [
                    {
                      "extension": [
                        {
                          "url": "lang",
                          "valueCode": "ru"
                        },
                        {
                          "url": "content",
                          "valueString": "Низкий риск (<5%)"
                        }
                      ],
                      "url": "http://hl7.org/fhir/StructureDefinition/translation"
                    },
                    {
                      "extension": [
                        {
                          "url": "lang",
                          "valueCode": "en"
                        },
                        {
                          "url": "content",
                          "valueString": "Low risk (<5%)"
                        }
                      ],
                      "url": "http://hl7.org/fhir/StructureDefinition/translation"
                    }
                  ]
                }
              }
            },
            {
              "valueCoding": {
                "system": "https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs",
                "code": "moderate",
                "display": "O'rtacha xavf (5% - <10%)",
                "_display": {
                  "extension": [
                    {
                      "extension": [
                        {
                          "url": "lang",
                          "valueCode": "ru"
                        },
                        {
                          "url": "content",
                          "valueString": "Умеренный риск (5% - <10%)"
                        }
                      ],
                      "url": "http://hl7.org/fhir/StructureDefinition/translation"
                    },
                    {
                      "extension": [
                        {
                          "url": "lang",
                          "valueCode": "en"
                        },
                        {
                          "url": "content",
                          "valueString": "Moderate risk (5% - <10%)"
                        }
                      ],
                      "url": "http://hl7.org/fhir/StructureDefinition/translation"
                    }
                  ]
                }
              }
            },
            {
              "valueCoding": {
                "system": "https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs",
                "code": "medium",
                "display": "O'rtacha xavf (10% - <20%)",
                "_display": {
                  "extension": [
                    {
                      "extension": [
                        {
                          "url": "lang",
                          "valueCode": "ru"
                        },
                        {
                          "url": "content",
                          "valueString": "Средний риск (10% - <20%)"
                        }
                      ],
                      "url": "http://hl7.org/fhir/StructureDefinition/translation"
                    },
                    {
                      "extension": [
                        {
                          "url": "lang",
                          "valueCode": "en"
                        },
                        {
                          "url": "content",
                          "valueString": "Medium risk (10% - <20%)"
                        }
                      ],
                      "url": "http://hl7.org/fhir/StructureDefinition/translation"
                    }
                  ]
                }
              }
            },
            {
              "valueCoding": {
                "system": "https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs",
                "code": "high",
                "display": "Yuqori xavf (20% - <30%)",
                "_display": {
                  "extension": [
                    {
                      "extension": [
                        {
                          "url": "lang",
                          "valueCode": "ru"
                        },
                        {
                          "url": "content",
                          "valueString": "Высокий риск (20% - <30%)"
                        }
                      ],
                      "url": "http://hl7.org/fhir/StructureDefinition/translation"
                    },
                    {
                      "extension": [
                        {
                          "url": "lang",
                          "valueCode": "en"
                        },
                        {
                          "url": "content",
                          "valueString": "High risk (20% - <30%)"
                        }
                      ],
                      "url": "http://hl7.org/fhir/StructureDefinition/translation"
                    }
                  ]
                }
              }
            },
            {
              "valueCoding": {
                "system": "https://terminology.dhp.uz/fhir/core/CodeSystem/cvd-risk-category-cs",
                "code": "very-high",
                "display": "Juda yuqori xavf (>=30%)",
                "_display": {
                  "extension": [
                    {
                      "extension": [
                        {
                          "url": "lang",
                          "valueCode": "ru"
                        },
                        {
                          "url": "content",
                          "valueString": "Очень высокий риск (>=30%)"
                        }
                      ],
                      "url": "http://hl7.org/fhir/StructureDefinition/translation"
                    },
                    {
                      "extension": [
                        {
                          "url": "lang",
                          "valueCode": "en"
                        },
                        {
                          "url": "content",
                          "valueString": "Very high risk (>=30%)"
                        }
                      ],
                      "url": "http://hl7.org/fhir/StructureDefinition/translation"
                    }
                  ]
                }
              }
            }
          ]
        },
        {
          "linkId": "recommendation-low",
          "text": "Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv 12 oydan keyin o'tkaziladi.",
          "_text": {
            "extension": [
              {
                "extension": [
                  {
                    "url": "lang",
                    "valueCode": "ru"
                  },
                  {
                    "url": "content",
                    "valueString": "Рекомендуется здоровый образ жизни, правильное питание, физическая активность, ограничение употребления табака (если пациент употребляет табачные изделия), ограничение употребления алкоголя (если пациент употребляет алкоголь). Повторное обследование через 12 месяцев."
                  }
                ],
                "url": "http://hl7.org/fhir/StructureDefinition/translation"
              },
              {
                "extension": [
                  {
                    "url": "lang",
                    "valueCode": "en"
                  },
                  {
                    "url": "content",
                    "valueString": "A healthy lifestyle, proper nutrition, physical activity, reduced tobacco use (if the patient uses tobacco products) and limited alcohol consumption (if the patient drinks alcohol) are recommended. Repeat assessment after 12 months."
                  }
                ],
                "url": "http://hl7.org/fhir/StructureDefinition/translation"
              }
            ]
          },
          "type": "display",
          "enableWhen": [
            {
              "question": "cvd-risk-score",
              "operator": "<",
              "answerInteger": 5
            }
          ]
        },
        {
          "linkId": "recommendation-moderate",
          "text": "Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Takroriy tekshiruv har uch oyda o'tkaziladi (arterial bosimning maqsadli darajasiga erishilganda - takroriy tekshiruvlar har 6-9 oyda amalga oshiriladi). Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'zlar ko'ruvi, EKG - 2 yilda 1 marta yoki ko'rsatma bo'yicha.",
          "_text": {
            "extension": [
              {
                "extension": [
                  {
                    "url": "lang",
                    "valueCode": "ru"
                  },
                  {
                    "url": "content",
                    "valueString": "Рекомендуется здоровый образ жизни, правильное питание, физическая активность, ограничение употребления табака (если пациент употребляет табачные изделия), ограничение употребления алкоголя (если пациент употребляет алкоголь). Повторные обследования каждые 3 месяца (при достижении артериального давления целевого уровня - повторные обследования каждые 6-9 месяцев). Мониторинг глюкозы в крови, холестерина, белка мочи, осмотр глаз, ЭКГ - 1 раз в 2 года или по назначению."
                  }
                ],
                "url": "http://hl7.org/fhir/StructureDefinition/translation"
              },
              {
                "extension": [
                  {
                    "url": "lang",
                    "valueCode": "en"
                  },
                  {
                    "url": "content",
                    "valueString": "A healthy lifestyle, proper nutrition, physical activity, reduced tobacco use (if the patient uses tobacco products) and limited alcohol consumption (if the patient drinks alcohol) are recommended. Repeat assessment every 3 months (once the blood pressure target is reached - every 6-9 months). Monitoring of blood glucose, cholesterol and urine protein, eye examination and ECG - once every 2 years or as prescribed."
                  }
                ],
                "url": "http://hl7.org/fhir/StructureDefinition/translation"
              }
            ]
          },
          "type": "display",
          "enableWhen": [
            {
              "question": "cvd-risk-score",
              "operator": ">=",
              "answerInteger": 5
            },
            {
              "question": "cvd-risk-score",
              "operator": "<",
              "answerInteger": 10
            }
          ],
          "enableBehavior": "all"
        },
        {
          "linkId": "recommendation-medium",
          "text": "Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta.",
          "_text": {
            "extension": [
              {
                "extension": [
                  {
                    "url": "lang",
                    "valueCode": "ru"
                  },
                  {
                    "url": "content",
                    "valueString": "Рекомендуется здоровый образ жизни, правильное питание, физическая активность, ограничение употребления табака (если пациент употребляет табачные изделия), ограничение употребления алкоголя (если пациент употребляет алкоголь). Мониторинг каждые 3-6 месяцев до достижения целевого уровня артериального давления. Мониторинг глюкозы в крови, холестерина, белка мочи, исследование глазного дна, ЭКГ - 1 раз в год по плану или по назначению. Осмотр кардиолога, терапевта плановый 1 раз в год или по назначению."
                  }
                ],
                "url": "http://hl7.org/fhir/StructureDefinition/translation"
              },
              {
                "extension": [
                  {
                    "url": "lang",
                    "valueCode": "en"
                  },
                  {
                    "url": "content",
                    "valueString": "A healthy lifestyle, proper nutrition, physical activity, reduced tobacco use (if the patient uses tobacco products) and limited alcohol consumption (if the patient drinks alcohol) are recommended. Monitoring every 3-6 months until the blood pressure target is reached. Monitoring of blood glucose, cholesterol and urine protein, fundus examination and ECG - once a year as scheduled or as prescribed. Cardiologist and general practitioner review - once a year as scheduled or as prescribed."
                  }
                ],
                "url": "http://hl7.org/fhir/StructureDefinition/translation"
              }
            ]
          },
          "type": "display",
          "enableWhen": [
            {
              "question": "cvd-risk-score",
              "operator": ">=",
              "answerInteger": 10
            },
            {
              "question": "cvd-risk-score",
              "operator": "<",
              "answerInteger": 20
            }
          ],
          "enableBehavior": "all"
        },
        {
          "linkId": "recommendation-high",
          "text": "Sog'lom turmush tarziga rioya qilish, to'g'ri ovqatlanish, jismoniy faollik, tamaki chekishni kamaytirish (agar bemor tamaki mahsulotlari iste'mol qilsa), spirtli ichimliklar iste'mol qilishni chegaralash (agar bemor alkogol mahsulotlari ichsa) tavsiya etiladi. Monitoring har 3-6 oyda - arterial bosim maqsadli darajasiga yetgunigacha o'tkaziladi. Qondagi glyukoza, xolesterin, siydikdagi oqsil monitoringi, ko'z tubi tekshiruvi, EKG - reja yoki ko'rsatma bo'yicha yilda 1 marta. Lipid spektri va qondagi kreatinin darajasi hamda koptokchali filtratsiya tezligi (KFT) hisobi reja yoki ko'rsatma bo'yicha yilda 1 marta. Kardiolog, terapevt ko'rigi - reja yoki ko'rsatma bo'yicha yilda 1 marta.",
          "_text": {
            "extension": [
              {
                "extension": [
                  {
                    "url": "lang",
                    "valueCode": "ru"
                  },
                  {
                    "url": "content",
                    "valueString": "Рекомендуется здоровый образ жизни, правильное питание, физическая активность, ограничение употребления табака (если пациент употребляет табачные изделия), ограничение употребления алкоголя (если пациент употребляет алкоголь). Мониторинг каждые 3-6 месяцев до достижения целевого уровня артериального давления. Мониторинг глюкозы в крови, холестерина, белка мочи, исследование глазного дна, ЭКГ - 1 раз в год по плану или по назначению. Определение липидного спектра и уровня креатинина в крови и расчёт скорости клубочковой фильтрации (СКФ) 1 раз в год в плановом порядке или по назначению. Осмотр кардиолога, терапевта - плановый 1 раз в год или по назначению."
                  }
                ],
                "url": "http://hl7.org/fhir/StructureDefinition/translation"
              },
              {
                "extension": [
                  {
                    "url": "lang",
                    "valueCode": "en"
                  },
                  {
                    "url": "content",
                    "valueString": "A healthy lifestyle, proper nutrition, physical activity, reduced tobacco use (if the patient uses tobacco products) and limited alcohol consumption (if the patient drinks alcohol) are recommended. Monitoring every 3-6 months until the blood pressure target is reached. Monitoring of blood glucose, cholesterol and urine protein, fundus examination and ECG - once a year as scheduled or as prescribed. Lipid profile, blood creatinine and glomerular filtration rate (GFR) calculation - once a year as scheduled or as prescribed. Cardiologist and general practitioner review - once a year as scheduled or as prescribed."
                  }
                ],
                "url": "http://hl7.org/fhir/StructureDefinition/translation"
              }
            ]
          },
          "type": "display",
          "enableWhen": [
            {
              "question": "cvd-risk-score",
              "operator": ">=",
              "answerInteger": 20
            }
          ]
        }
      ]
    }
  ]
}